Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi

BACKGROUND: Pre-treatment drug resistance (PDR) among antiretroviral drug-naïve people living with HIV (PLHIV) represents an important indicator for the risk of treatment failure and the spread of drug resistant HIV variants. We assessed the prevalence of PDR and treatment outcomes among adults livi...

Descripción completa

Detalles Bibliográficos
Autores principales: Neuhann, F., de Forest, A., Heger, E., Nhlema, A., Scheller, C., Kaiser, R., Steffen, H. M., Tweya, H., Fätkenheuer, G., Phiri, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240935/
https://www.ncbi.nlm.nih.gov/pubmed/32434561
http://dx.doi.org/10.1186/s12981-020-00282-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240935/
https://www.ncbi.nlm.nih.gov/pubmed/32434561
http://dx.doi.org/10.1186/s12981-020-00282-3

Ejemplares similares